Inserm, CIC-P 0203 Clinical Investigation Centre, Rennes, France.
Br J Clin Pharmacol. 2013 Feb;75(2):423-30. doi: 10.1111/j.1365-2125.2012.04359.x.
A single administration of hydrocortisone has been shown to enhance the pressor response to phenylephrine in healthy volunteers and to norepinephrine in septic shock patients. Similar data do not exist for fludrocortisone. Since there continues to be disagreement about the utility of fludrocortisone in septic shock, we assessed the effects of a single administration of low doses of hydrocortisone (50 mg intravenously) and fludrocortisone (50 μg orally), given either alone or in combination, on phenylephrine mean arterial pressure and cardiac systolic and diastolic function dose-response relationships in 12 healthy male volunteers with hypo-aldosteronism induced by intravenous sodium loading.
This was a placebo-controlled, randomized, double-blind, crossover study performed according to a 2 × 2 factorial design. Subjects received first a 2000 ml infusion of NaCl 0.9% during 2 h. Then fludrocortisone 50 μg (or its placebo) was administered orally and hydrocortisone 50 mg (or its placebo) was injected intravenously. At 1.5 h after treatment administration, incremental doses of phenylephrine were infused (from 0.01 to 3 μg kg(-1) min(-1)), each dose being infused during 5 min.
Both fludrocortisone (P < 0.001) and hydrocortisone (P = 0.002) induced a significant decrease in pressor response to phenylephrine, their effects being additive (fludrocortisone × hydrocortisone interaction, P = 0.792). The two drugs did not induce any detectable cardiac effect.
Single administrations of fludrocortisone and hydrocortisone decreased the pressor response to phenylephrine in healthy volunteers with hypo-aldosteronism. These similar effects of hydrocortisone and fludrocortisone probably express a rapid non-genomic vasodilating effect of the two steroids in the context of acute volume loading.
单次给予氢化可的松可增强健康志愿者对去氧肾上腺素的升压反应,并增强败血症休克患者对去甲肾上腺素的升压反应。类似的数据在氟氢可的松中并不存在。由于在败血症休克中氟氢可的松的效用仍存在争议,我们评估了单次给予低剂量氢化可的松(50mg 静脉内)和氟氢可的松(50μg 口服),单独或联合给予,对 12 名因静脉内钠负荷引起低醛固酮血症的健康男性志愿者去氧肾上腺素平均动脉压和心脏收缩及舒张功能剂量反应关系的影响。
这是一项安慰剂对照、随机、双盲、交叉研究,按照 2×2 析因设计进行。受试者首先接受 2 小时内输注 2000ml 生理盐水。然后给予氟氢可的松 50μg(或其安慰剂)口服,给予氢化可的松 50mg(或其安慰剂)静脉内注射。治疗后 1.5 小时,开始输注递增剂量的去氧肾上腺素(从 0.01 至 3μg·kg-1·min-1),每次剂量输注 5 分钟。
氟氢可的松(P<0.001)和氢化可的松(P=0.002)均显著降低去氧肾上腺素的升压反应,其作用具有相加性(氟氢可的松×氢化可的松相互作用,P=0.792)。两种药物均未引起可检测到的心脏作用。
单次给予氟氢可的松和氢化可的松可降低低醛固酮血症健康志愿者对去氧肾上腺素的升压反应。氢化可的松和氟氢可的松的这些相似作用可能表达了两种类固醇在急性容量负荷下的快速非基因组血管扩张作用。